2024-09-10 - Analysis Report
## Lilly (LLY) Stock Analysis:

**Company Overview:** Eli Lilly and Company is a global pharmaceutical company specializing in the research, development, and manufacturing of medicines.

**Performance Analysis:**

**1. Return Comparison:**

* **LLY Cumulative Return:** 528.7
* **VOO (S&P 500) Cumulative Return:** 81.34
* **Relative Divergence:** 447.36 (93.09% relative to historical range)

LLY has significantly outperformed the S&P 500, showing a much higher cumulative return. This places it at a high level within its historical performance range.

**2. Recent Price Movement:**

* **Closing Price:** $902.71
* **5-Day Moving Average:** $935.66
* **20-Day Moving Average:** $933.63
* **60-Day Moving Average:** $893.73

The stock price is currently below its 5-day and 20-day moving averages, indicating a short-term downtrend. However, it is above the 60-day moving average, which suggests a longer-term uptrend.

**3. Technical Indicators:**

* **RSI:** 42.63 (Neutral, indicating neither overbought nor oversold conditions)
* **PPO:** -0.59 (Negative, suggesting potential for downward momentum)
* **Delta_Previous_Relative_Divergence:** 6.22 (Positive, indicating short-term upward momentum)
* **Expected Return:** 33.33% (Max 5-year return on invested capital)

The technical indicators suggest mixed signals, with short-term momentum leaning towards upward while long-term indicators point towards potential downtrend. The positive expected return suggests potential for growth.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-08-08 | 3.29 | $11.30 B |
| 2024-04-30 | 2.49 | $8.77 B |
| 2023-11-02 | -0.06 | $9.50 B |
| 2023-08-08 | 1.96 | $8.31 B |
| 2024-08-08 | 1.96 | $8.31 B |

Lilly's recent earnings have shown positive growth, with the latest quarter surpassing expectations. This demonstrates the company's strong performance and potential for future growth.

**Overall Analysis:**

LLY presents an interesting case. While the stock is currently experiencing short-term weakness, its strong long-term performance, positive earnings, and expected return suggest potential for future growth. The technical indicators provide mixed signals, requiring further analysis for better understanding. Investors should consider their risk tolerance and investment goals when deciding if LLY aligns with their portfolio strategy.
